CAS: 40524-99-0

Cannabicyclolic Acid is a cannabinoid derivative that has been shown to be an antimicrobial agent. It was found to inhibit the growth of bacteria and fungi, including Candida albicans. Cannabicyclolic Acid is also an ATP-binding cassette transporter inhibitor, which prevents fatty acids from entering the cell. Fatty acids are involved in a number of physiological processes, such as surfactant production and atp-binding cassette transporter function. The inhibition of this enzyme can lead to metabolic disorders and autoimmune diseases. Cannabicyclolic Acid has been shown to be a diagnostic marker for glomerular filtration rate (GFR) and biochemical properties in patients suffering from renal disease.